Back to Reference Library
farriery
veterinary
biomechanics
anatomy
nutrition
physiotherapy
2009
Case Report

Differential association of MUC5AC and CLCA1 expression in small cartilaginous airways of RAO-affected and control horses.

Authors: Gerber V, De Feijter-Rupp H, Wagner J, Venta P, Harkema J R, Robinson N E

Journal: Equine veterinary journal

Summary

# Editorial Summary Recurrent airway obstruction (RAO) in horses is characterised by excessive mucus accumulation in small airways, particularly when animals are exposed to dust and allergens in indoor environments; this study investigated whether dysregulation of specific mucin-producing genes and chloride channel expression underpin this pathological response. Researchers examined airway tissue samples from RAO-affected and control horses, measuring the expression patterns of MUC5AC (a major mucin gene) and CLCA1 (a calcium-activated chloride channel implicated in mucin secretion) in small cartilaginous airways using molecular and immunohistochemical techniques. The findings revealed differential expression of both genes between diseased and healthy horses, suggesting that aberrant signalling through EGFR-mediated pathways may drive excessive mucin production in susceptible individuals. Understanding these molecular mechanisms has direct implications for therapeutic intervention—targeting mucin gene expression or chloride channel function could offer novel pharmacological approaches beyond traditional environmental management and corticosteroid treatment. For practitioners managing RAO cases, these findings underscore that airway mucus overproduction is not merely a consequence of irritation, but reflects altered cellular signalling that may be amenable to disease-modifying rather than purely symptomatic treatment strategies.

Read the full abstract on PubMed

Practical Takeaways

  • Understanding the molecular mechanisms of mucus overproduction in RAO can help inform management strategies focused on reducing indoor irritant and allergen exposure
  • MUC5AC and CLCA1 may serve as biomarkers for assessing airway inflammation severity and response to environmental modifications in RAO cases
  • Targeting EGFR and CLCA1 signalling pathways represents a potential therapeutic avenue for managing mucus accumulation in horses with RAO

Key Findings

  • MUC5AC and CLCA1 expression patterns differ between RAO-affected and control horses in small cartilaginous airways
  • EGFR and CLCA1 are key signalling molecules involved in mucin gene expression in equine airways
  • Indoor irritant and allergen exposure is associated with airway mucus accumulation in RAO-affected horses

Conditions Studied

recurrent airway obstruction (rao)airway mucus accumulationsmall cartilaginous airway disease